TheScreener
Fundamental and technical screening for 1,000 listed companies.
Use ⌘K to search stocks, screens, and features instantly.
Archean Chemical Industries Ltd.
ACISmall CapNSEBSE
Chemical Manufacturing · Chemicals
₹485.45up 1.15up 0.24 percentas of 31 Aug 2026
Book value ₹157.10Div yield 0.51%
Key metrics
- Market Cap
- 5,990.20 ₹ cr
- P/E
- 55.97 x
- P/B
- 3.09 x
- ROE
- 5.52%
- ROCE
- 6.67%
- Debt to Equity
- 0.24 x
- Net Margin
- 9.88%
- Dividend Yield
- 0.51%
- Revenue Growth (YoY)
- 11.92%
Observations
Mechanical observations generated from stored data, not analysis or opinion. Each one names the threshold that produced it — the ROCE check below uses 20%, a fixed default rather than a value tailored to this company.
- ROCE above 20% in 1 of the last 3 financial years (2023-2024, 2024-2025, 2025-2026).
- Revenue declined year-on-year in 2 of the last 3 years.
- Net margin declined year-on-year in each of the last 3 years.
- Promoter holding 53.4% (pledge data not available).
- Debt-to-equity 0.24 — below the Chemicals median of 0.40.
ACI
₹485.45up 0.24 percent
EOD Synced: 31 Aug 2026 18:30 ISTOverview & Live Price Chart
Executive Investment Verdict & Quality Synthesis
Autonomous V2Multi-dimensional quantitative synthesis across capital efficiency, forensic accounting, intrinsic valuation, and ownership governance.
Factual Quantitative Consensus
1. Capital Efficiency & MoatCapital Intensive
6.67%ROCE
ROE: 5.52%·P/B: 3.09x
2. Forensic Health & SolvencyPiotroski 4/9 · Adequate Health
4/9Piotroski Score
Altman: 4.6 (Safe Zone)
3. Valuation & DCF Spread+27.7% Margin of Safety
₹620DCF Fair Value
CMP: ₹485.5
4. Ownership & GovernanceClean Promoter Holding
53.43%Promoter Stake
Pledged: 0.0%·Inst: 27.15%
Institutional Factor Scores
QVGM Factor Grade Matrix
Institutional Multi-Factor Profile (QVGM)
Composite 0–100 percentile ranks normalized across all 500 universe constituents
Rank #36 of 37 in Chemical ManufacturingQVGM 26/100
Quality (Q)35
ROE, ROCE, Margins & Cash Conversion
Value (V)42
P/E, P/B, EV/EBITDA vs Sector Benchmarks
Growth (G)4
3Y Sales & EPS Compounded Growth
Momentum (M)19
Relative Strength & Trend Position
TheScreener Radar™ 5-Pillar Quantitative Scorecard
Holistic quantitative radar evaluating fundamental quality, valuation multiples, balance sheet health, growth, and price momentum
Sector Rank:Rank #36 of 37 in Chemical Manufacturing
Valuation
Moderate42/100
P/E Ratio:55.97x
P/B Ratio:3.09x
Dividend Yield:0.51%
P/E, P/B, EV/EBITDA & Dividend Yield relative to 5Y medians and sector
Growth
Weak4/100
3Y Sales CAGR:—
3Y PAT CAGR:—
Quarterly YoY:+12.4%
3-Year Compounded Sales & Net Profit Growth trajectory
Profitability
Weak35/100
ROE:5.5%
ROCE:6.7%
OPM %:—
Return on Equity (ROE), ROCE & Operating Margin efficiency
Solvency & Health
Moderate44/100
Piotroski F-Score:4/9
Altman Z-Score:4.56
Debt / Equity:0.00
Balance Sheet strength, Altman Z-Score & Piotroski F-Score checklist
Momentum
Weak19/100
1Y Return:—
RSI (14):54.2
From 52W High:—
1-Year Relative Strength vs NIFTY 500, RSI-14 & 52W High distance
Quantitative Drivers & Growth Analysis
52-week corridor, deep valuation multiples, compounded CAGR trajectory, and institutional flow shifts
52-Week Low₹483.95
From 52W High-32.16%
52-Week High₹715.60
Valuation MultiplesCash Flow & Yield
PEG Ratio—
Earnings Yield1.76%
Price / FCF—
FCF Yield-4.05%
Payout Ratio29.34%
Net-Net Ratio-3.32
Solvency & SafetyPiotroski & Altman
Piotroski F-Score4/9
Altman Z-Score4.56
Graham Number₹173.54
1Y Flow & Margin ShiftsTrailing 12M
FII Stake:▼ 0.09%
DII Stake:▼ 0.96%
OPM Margin:▼ 5.03%
Net Margin:▼ 5.69%
Compounded Annual Growth Rate (CAGR Matrix)
Historical Fundamental Trajectory| Metric | QoQ Shift | YoY Shift | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|---|
| Revenue Growth | ▲ +8.73% | ▲ +11.92% | 3.85% | -9.14% | 7.85% |
| Net Profit Growth | ▲ +120.09% | ▼ 23.66% | -34.10% | -34.63% | 9.92% |
| EPS Growth | ▲ +119.47% | ▼ 23.69% | -45.03% | -37.31% | 9.43% |
Intrinsic Valuation Models & DCF Sensitivity
Institutional DCF & Intrinsic Valuation Studio — ACI
2-Stage Discounted Cash Flow, Reverse DCF Implied Growth, and Benjamin Graham & Peter Lynch valuation benchmarks.
DCF Intrinsic Fair Value
₹635.4
Verdict:Undervalued (+30.9%)
Benjamin Graham Number
₹173.3
-64.3% vs CMPPeter Lynch Fair Value
₹42.6
-91.2% vs CMPReverse DCF Implied Growth
-20.0% CAGR
Modest Expectations (High Margin of Safety)Valuation Spectrum PositioningCMP: ₹485.5
₹0 (Distress)CMP: ₹485DCF: ₹635Graham: ₹173
Scenario Calibration & Sensitivity Levers
Tune Discount Rate (WACC), 5-Year Growth, and Terminal Value to model bear, base, and bull cases.
Discount Rate (WACC)11.5%
Cost of Capital Hurdle
5-Year FCF Growth CAGR6.0%
Assumed stage-1 cash flow expansionTerminal Growth Rate4.5%
Long-term perpetual GDP growth rate5-Year Projected Cash Flow Schedule (₹ Cr)
| Projection Period | Growth Rate | Projected FCF | Discount Factor | Present Value |
|---|---|---|---|---|
| Year 1 | 6% | ₹553 | 0.8969 | ₹496 |
| Year 2 | 6% | ₹586 | 0.8044 | ₹472 |
| Year 3 | 6% | ₹621 | 0.7214 | ₹448 |
| Year 4 | 6% | ₹659 | 0.6470 | ₹426 |
| Year 5 | 6% | ₹698 | 0.5803 | ₹405 |
2D Sensitivity Matrix (WACC vs Terminal Growth Rate)
Click any cell to apply WACC & terminal growth scenario. Values in ₹ / share.| WACC \ g(Terminal) | 3.0% | 4.0% | 4.5% | 5.0% | 6.0% |
|---|---|---|---|---|---|
| 10.0% | ₹670 +38% | ₹761 +57% | ₹820 +69% | ₹890 +83% | ₹1083 +123% |
| 11.0% | ₹580 +19% | ₹647 +33% | ₹687 +42% | ₹735 +51% | ₹859 +77% |
| 11.5% | ₹543 +12% | ₹601 +24% | ₹635 +31% | ₹676 +39% | ₹778 +60% |
| 12.0% | ₹510 +5% | ₹560 +15% | ₹590 +22% | ₹625 +29% | ₹710 +46% |
| 13.0% | ₹455 -6% | ₹493 +2% | ₹516 +6% | ₹542 +12% | ₹603 +24% |
Discounted cash flow (DCF) and valuation models are quantitative projections based on user-supplied assumptions — not a forecast, not a guarantee of future performance, and not SEBI-registered investment advice. Actual financial performance and stock price movements may differ materially.
New to intrinsic valuation models? Learn how Discounted Cash Flow and Terminal Growth rates work.Read DCF Academy Guide →
Valuation history
P/E55.97current
ReportedComputed, approximate
P/B3.09current
ReportedComputed, approximate
The dashed line is computed from historical close price divided by the most recently reported annual EPS or book value — not IndianAPI's own figure, which only ever gives a single current reading with no history behind it. Real results are typically disclosed several weeks after the fiscal year ends, so a computed point right around a year transition can lag what the market actually knew that day. The solid line is the real reported figure.
EV/EBITDA is not shown — there is no verified source for it in our data feed, and estimating it would misrepresent an estimate as a reported figure.
| Date | P/E | P/B |
|---|---|---|
| 31 Aug 2026 | 55.97 | 3.09 |
Analyst Consensus, Price Targets & Forecasts
Analyst Consensus & Recommendations
Aggregated institutional equity research ratings · 31 Aug 2026
Hold(2.75 / 5)
Strong Buy:1
Buy:0
Hold:2
Sell:1
Strong Sell:0
Coverage: 4 contributing analystsScale: 1 (Strong Buy) – 5 (Strong Sell)
Ratings shown are third-party analyst estimates compiled from institutional brokers. They do not constitute investment advice.
Risk Profile & Volatility
Statistical return volatility classification · 31 Aug 2026
Balanced risk
Low RiskModerate RiskHigh Risk
Annualised Standard Deviation:34.39%
Analyst Price Targets
12-month forward price consensus · 31 Aug 2026
Upside: +24.83%
Mean Target₹606.00vs CMP ₹485.45
High Target₹800.00+64.8% max upside
Low Target₹523.007.7% downside
Median Target₹552.004 estimates
Low: ₹523.00Mean: ₹606.00High: ₹800.00
Mean Target Current Price (₹485.45)
Price targets are third-party analyst estimates compiled from institutional brokers. They do not constitute investment advice.
Forward Financial Forecasts & Consensus Estimates
Institutional broker consensus estimates and forward earnings trajectory
FY2023EConsensus
Mean Estimate
—
Low:—
High:—
FY2023EConsensus
Mean Estimate
—
Low:—
High:—
FY2023EConsensus
Mean Estimate
₹11.05
Low:—
High:—
FY2023EConsensus
Mean Estimate
—
Low:—
High:—
FY2024E1 Analysts
Mean Estimate
₹4.64
Low:—
High:—
FY2024EConsensus
Mean Estimate
₹7.60
Low:—
High:—
FY2024EConsensus
Mean Estimate
₹5.34
Low:—
High:—
FY2024E1 Analysts
Mean Estimate
₹8.23
Low:—
High:—
FY2025EConsensus
Mean Estimate
₹3.88
Low:—
High:—
FY2025E2 Analysts
Mean Estimate
₹3.63
Low:—
High:—
FY2025E1 Analysts
Mean Estimate
₹4.50
Low:—
High:—
FY2025EConsensus
Mean Estimate
₹4.33
Low:—
High:—
FY2026E1 Analysts
Mean Estimate
₹3.25
Low:—
High:—
FY2026EConsensus
Mean Estimate
₹2.36
Low:—
High:—
| Period / Fiscal Year | Consensus Mean | Bull Case (High) | Bear Case (Low) | Brokers |
|---|---|---|---|---|
| FY2023 Forecast | — | — | — | — |
| FY2023 Forecast | — | — | — | — |
| FY2023 Forecast | ₹11.05 | — | — | — |
| FY2023 Forecast | — | — | — | — |
| FY2024 Forecast | ₹4.64 | — | — | 1 |
| FY2024 Forecast | ₹7.60 | — | — | — |
| FY2024 Forecast | ₹5.34 | — | — | — |
| FY2024 Forecast | ₹8.23 | — | — | 1 |
| FY2025 Forecast | ₹3.88 | — | — | — |
| FY2025 Forecast | ₹3.63 | — | — | 2 |
| FY2025 Forecast | ₹4.50 | — | — | 1 |
| FY2025 Forecast | ₹4.33 | — | — | — |
| FY2026 Forecast | ₹3.25 | — | — | 1 |
| FY2026 Forecast | ₹2.36 | — | — | — |
Third-party broker forecasts compiled from institutional research houses, not IndiScreener's proprietary estimates. Provided strictly for analytical benchmarking and does not constitute investment advice.
Forensic Accounting Audit & Solvency Risk
Accounting Health & Governance Quality Radar
Algorithmic accounting analysis across balance sheet solvency, cash conversion efficiency, and ownership stability.
Clean Governance & Solvency
Financial Strengths & Catalysts
4 Factors- •Company maintains conservative leverage with D/E of 0.24x.
- •Strong cash generation: Operating Cash Flow is 130.7% of reported Net Profit.
- •High promoter holding of 53.4% with zero encumbrance / pledge.
- •High institutional backing: FIIs & DIIs hold a combined 27.1%.
Risk Factors & Watchouts
1 Watchout- •Return on Equity (ROE) is currently modest at 5.5%.
Forensic Accounting & Health Audit
Piotroski F-Score, Altman Z-Score Distress Model & Beneish Earnings Manipulation Checks
Piotroski F-Score4 / 9
● Moderate (Neutral)
Altman Z-Score4.56
● Safe Zone
Negligible risk of financial distress over the next 2 years.
Beneish M-Score-2.10
● Low Risk (Clean Accounting)
Cash flows closely match reported earnings with conservative accruals.
Learn how Piotroski F-Score (9 criteria) and Altman Z-Score detect earnings manipulation and bankruptcy risk.Read Forensic Guide →
10-Year Financial Statements & DuPont ROE
Financial Statements
consolidated · amounts in ₹ Crores
Accounting Flow:
Wall Street Cash Flow & Free Cash Flow (FCF) Cascade
FY26 (2025-2026)3-Stage institutional flow from reported earnings to owner Free Cash Flow and capital allocation
FCF Conversion Rate (FCF / PAT)
-227.0%Low Cash Conversion
Measures how much reported accounting profit turns into real liquid cash.
Free Cash Flow Margin
-22.4%of Gross Revenue
Liquid cash retained per ₹100 of top-line revenue generated.
CapEx Reinvestment Rate
273.7%of Operating Cash
Portion of operating cash reinvested in future capacity and maintenance.
Reported Net Profit (PAT)₹107 CrInflow
107
+ D&A Non-Cash Charge₹93 CrAdd-back
93
Working Capital Adjustment-₹60 Cr- Tied Up
60
= Operating Cash Flow (CFO)₹140 CrOperating Cash
140
- Capital Expenditures (CapEx)-₹382 CrReinvestment
382
= Free Cash Flow (FCF)-₹243 CrFree Cash Flow
243
- Dividends & Debt Repayment-₹24 CrCapital Return
24
= Net Change in Cash-₹267 CrNet Balance
267
Multi-Year Historical FCF vs Reported PAT Trajectory:
Free Cash Flow (FCF) Reported Net Profit (PAT)
| Metric | 2019-202031 Mar 2020 | 2020-202131 Mar 2021 | 2021-202231 Mar 2022 | 2022-202331 Mar 2023 | 2023-202431 Mar 2024 | 2024-202531 Mar 2025 | 2025-202631 Mar 2026 |
|---|---|---|---|---|---|---|---|
| Revenue | ₹608.17 | ₹740.76 | ₹1,130.44 | ₹1,441.07 | ₹1,330.09 | ₹1,041.02 | ₹1,081.05 |
| Operating profit | ₹96.23 | ₹207.27 | ₹400.27 | ₹565.36 | ₹395.37 | ₹195.46 | ₹148.60 |
| OPM | 15.82% | 27.98% | 35.41% | 39.23% | 29.73% | 18.78% | 13.75% |
| Net profit | ₹-36.22 | ₹66.59 | ₹188.58 | ₹382.56 | ₹318.98 | ₹162.15 | ₹106.86 |
| EPS | -2.93 | 5.43 | 15.32 | 34.58 | 25.69 | 15.50 | 8.52 |
| Net margin | -5.96% | 8.99% | 16.68% | 26.55% | 23.98% | 15.58% | 9.88% |
| ROE | -604.67% | 90.01% | 71.90% | 26.73% | 18.75% | 8.70% | 5.52% |
| ROCE | 8.19% | 16.56% | 29.52% | 35.71% | 20.58% | 8.90% | 6.67% |
| Debt / equity | 150.12 | 12.18 | 3.42 | 0.05 | 0.06 | 0.13 | 0.24 |
Compounded growth (CAGR)
| Metric | 1Y | 3Y | 5Y |
|---|---|---|---|
| Revenue | 3.85% | -9.14% | 7.85% |
| Net profit | -34.10% | -34.63% | 9.92% |
| EPS | -45.03% | -37.31% | 9.43% |
Each column only appears when 7 real reported years actually support it — never extrapolated from fewer.
Balance sheet
| Metric | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 | 2025-2026 |
|---|---|---|---|---|---|---|---|
| Total assets | ₹1,428.62 | ₹1,434.03 | ₹1,531.31 | ₹1,755.43 | ₹2,055.86 | ₹2,393.43 | ₹2,664.78 |
| Total liabilities | ₹1,422.63 | ₹1,360.05 | ₹1,269.03 | ₹324.41 | ₹354.31 | ₹529.42 | ₹730.39 |
| Total equity | ₹5.99 | ₹73.98 | ₹262.29 | ₹1,431.02 | ₹1,701.55 | ₹1,864.01 | ₹1,934.39 |
| Total debt | ₹899.19 | ₹900.81 | ₹897.23 | ₹69.39 | ₹97.82 | ₹234.58 | ₹466.38 |
| Cash | ₹0.29 | — | ₹0.03 | ₹1.47 | ₹2.68 | ₹6.39 | ₹17.23 |
| Current assets | ₹262.19 | ₹300.59 | ₹398.65 | ₹576.72 | ₹726.16 | ₹691.39 | ₹531.38 |
| Current liabilities | ₹253.53 | ₹182.28 | ₹175.59 | ₹172.41 | ₹134.87 | ₹197.28 | ₹438.35 |
| Inventory | ₹98.82 | ₹110.63 | ₹120.79 | ₹186.68 | ₹140.82 | ₹195.43 | ₹245.37 |
| Receivables | ₹44.46 | ₹68.07 | ₹152.97 | ₹117.74 | ₹156.73 | ₹165.03 | ₹127.62 |
| Payables | ₹167.12 | ₹111.78 | ₹112.29 | ₹95.55 | ₹99.81 | ₹105.05 | ₹105.23 |
| Net PP&E | ₹1,073.58 | ₹1,061.10 | ₹1,103.25 | ₹1,146.09 | ₹1,205.78 | ₹1,442.83 | ₹1,454.67 |
| Retained earnings | ₹-168.42 | ₹-100.70 | ₹87.61 | ₹470.46 | ₹733.70 | ₹894.87 | ₹964.47 |
Cash flow
| Metric | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 | 2025-2026 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | ₹147.55 | ₹119.10 | ₹314.52 | ₹496.09 | ₹379.35 | ₹176.23 | ₹139.63 |
| Capital expenditure | ₹-152.03 | ₹-10.55 | ₹-96.61 | ₹-99.86 | ₹-207.89 | ₹-263.57 | ₹-382.16 |
| Free cash flow | ₹-4.48 | ₹108.55 | ₹217.91 | ₹396.23 | ₹171.46 | ₹-87.34 | ₹-242.53 |
| OCF / net profit | -4.07 | 1.79 | 1.67 | 1.30 | 1.19 | 1.09 | 1.31 |
| FCF / Capex intensity | 25.00 | 1.42 | 8.55 | 6.93 | 15.63 | 25.32 | 35.35 |
Income statement detail
| Metric | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 | 2025-2026 |
|---|---|---|---|---|---|---|---|
| Gross profit | ₹607.83 | ₹731.87 | ₹1,091.12 | ₹1,438.34 | ₹1,143.72 | ₹932.45 | ₹896.50 |
| Cost of revenue | ₹0.34 | ₹8.89 | ₹39.32 | ₹2.73 | ₹186.37 | ₹108.57 | ₹184.55 |
| EBITDA | ₹147.99 | ₹262.65 | ₹467.15 | ₹633.99 | ₹465.71 | ₹274.84 | ₹241.49 |
| Income before tax | ₹-16.69 | ₹90.48 | ₹250.99 | ₹511.68 | ₹427.18 | ₹223.77 | ₹147.10 |
| Interest expense | ₹120.40 | ₹118.60 | ₹155.88 | ₹73.26 | — | — | — |
| Tax expense | ₹19.53 | ₹23.89 | ₹62.41 | ₹129.12 | ₹108.21 | ₹61.62 | ₹41.69 |
| D&A | ₹51.76 | ₹55.38 | ₹66.88 | ₹68.63 | ₹70.34 | ₹79.38 | ₹92.89 |
| EBITDA margin | 24.33% | 35.46% | 41.32% | 43.99% | 35.01% | 26.40% | 22.34% |
Financial ratios
| Metric | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 | 2025-2026 |
|---|---|---|---|---|---|---|---|
| Current ratio | 1.03 | 1.65 | 2.27 | 3.35 | 5.38 | 3.50 | 1.21 |
| Quick ratio | 0.64 | 1.04 | 1.58 | 2.26 | 4.34 | 2.51 | 0.65 |
| Interest coverage | 0.80 | 1.75 | 2.57 | 7.72 | — | — | — |
| Inventory days | — | — | 1,121.27 | — | 275.79 | 657.01 | 485.29 |
| Receivable days | 26.68 | 33.54 | 49.39 | 29.82 | 43.01 | 57.86 | 43.09 |
| Payable days | — | — | 1,042.37 | — | 195.47 | 353.17 | 208.12 |
| Cash conversion cycle | — | — | 128.30 | — | 123.33 | 361.71 | 320.26 |
| Working capital days | — | — | — | — | — | — | — |
| Fixed asset turnover | 0.57 | 0.70 | 1.02 | 1.26 | 1.10 | 0.72 | 0.74 |
| ROA | -2.54% | 4.64% | 12.31% | 21.79% | 15.52% | 6.77% | 4.01% |
| ROIC | 23.08% | — | 25.94% | 28.20% | 16.43% | 6.77% | 4.47% |
| Gross margin | 99.94% | 98.80% | 96.52% | 99.81% | 85.99% | 89.57% | 82.93% |
DuPont 3-Stage ROE Factor Decomposition
Deconstructing Return on Equity into Profitability, Asset Efficiency, and Financial Leverage
Balanced Return EngineFY2025-2026
Net marginProfitability
9.88%
Net Profit generated per ₹100 of revenue (Profitability)
×
Asset turnoverEfficiency
0.41
Revenue generated per ₹1 of total assets (Capital Efficiency)
×
Equity multiplierLeverage
1.38
Total assets supported per ₹1 of shareholder equity (Leverage)
=
Implied DuPont ROEFinal Output
5.52%
Reported: 5.52%
Explore the 3-Stage DuPont Formula: Net Margin × Asset Turnover × Leverage Multiplier.Read DuPont Guide →
Corporate Actions, Dividends & Capital Changes
Chronological Corporate Actions Registry
Historical stock splits, bonus shares, rights issues, and corporate schemes
| Year | Execution Date | Action Type | Ratio / Term |
|---|---|---|---|
| 2026 | 05 Jun 2026 | dividend | 125% |
| 2025 | 26 May 2025 | dividend | 150% |
| 2024 | 21 Jun 2024 | dividend | 50% |
| 14 Feb 2024 | dividend | 50% | |
| 2023 | 17 Nov 2023 | dividend | 50% |
| 21 Jul 2023 | dividend | 125% |
Dividend Intelligence & Capital Return History
Historical cash payout track record across 6 dividend distributions
Latest Year DPS:₹2.50
Yield on CMP:0.51%
3Y Dividend CAGR:-10.6%
Annual Dividend Payout Progression (Per Share)Total Cumulative DPS: ₹11.00
₹2.5
2026
₹3.0
2025
₹2.0
2024
₹3.5
2023
| Ex-Date | Amount (Per Share) | Dividend Type |
|---|---|---|
| 05 Jun 2026 | ₹2.50 | Final |
| 26 May 2025 | ₹3.00 | Final |
| 21 Jun 2024 | ₹1.00 | Final |
| 14 Feb 2024 | ₹1.00 | Interim |
| 17 Nov 2023 | ₹1.00 | Interim |
| 21 Jul 2023 | ₹2.50 | Final |
Industry Peer Group & Valuation Spread
Compare valuation multiples and market cap relative to sector competitors
ChemicalsCompare Peers in Studio
Market Cap5,990.20 ₹ cr
Beats 14% of 43 industry peers · median 16,373.68 ₹ cr
P/E55.97 x
Beats 64% of 36 industry peers · median 43.05 x
P/B3.09 x
Beats 32% of 37 industry peers · median 4.30 x
ROE5.52%
Beats 28% of 43 industry peers · median 9.22%
ROCE6.67%
Beats 28% of 43 industry peers · median 10.48%
Debt to Equity0.24 x
Beats 23% of 43 industry peers · median 0.40 x
Net Margin9.88%
Beats 63% of 43 industry peers · median 9.10%
Dividend Yield0.51%
Beats 46% of 39 industry peers · median 0.61%
Revenue Growth (YoY)11.92%
Beats 26% of 43 industry peers · median 23.97%
| Company | Market Cap ▼ | P/E | P/B |
|---|---|---|---|
Solar Industries India Ltd.SOLARINDS | ₹1.84 L | 110.04 | 29.41 |
Pidilite Industries Ltd.PIDILITIND | ₹1.66 L | 68.98 | 15.56 |
SRF Ltd.SRF | ₹75,884.75 | 41.83 | 5.47 |
Coromandel International Ltd.COROMANDEL | ₹56,135.26 | 28.86 | 4.49 |
Linde India Ltd.LINDEINDIA | ₹54,832.00 | 101.04 | 13.00 |
Peers are chosen strictly by industry classification. A classification doesn't always describe what a company actually competes in, but gives an objective starting point across the universe.
Regulatory Filings & Market Intelligence
Corporate Document & Filings Vault
No statutory exchange announcements or PDF filings have been recorded for ACI yet.
News
- IndianAPIBuy or sell: Vaishali Parekh recommends three stocks to buy today — 24 September 2025
Buy or sell: Vaishali Parekh recommends three stocks to buy today — Archean Chemical Industries, Orient Cement, HCC
For informational and educational purposes only. Not investment advice. Data may be delayed or incomplete. Consult a SEBI-registered investment adviser before making investment decisions.